{"id":10827,"date":"2026-05-26T15:01:00","date_gmt":"2026-05-26T13:01:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=5f24320682e816edc4d974a80d107f48"},"modified":"2026-05-26T15:01:00","modified_gmt":"2026-05-26T13:01:00","slug":"beone-medicines-to-present-at-the-goldman-sachs-47th-annual-global-healthcare-conference","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=10827","title":{"rendered":"BeOne Medicines to Present at the Goldman Sachs 47th Annual Global Healthcare Conference"},"content":{"rendered":"

SAN CARLOS, Calif.--(BUSINESS WIRE)--$ONC<\/a> #BeOne<\/a>--BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will participate in the Goldman Sachs 47th Annual Global Healthcare Conference on June 8, 2026, with a fireside chat at 10:00 a.m. EDT.<\/p><\/a><\/a>

\nThe live webcast of this event can be accessed from the investors section of the Company\u2019s website at https:\/\/ir.beonemedicines.com<\/a>. An archived webcast will be available on the Company\u2019s website.<\/p>

\nAbout BeOne\n<\/b>BeOne Medicines is a global oncology company that is discovering and developing innovative treatments for cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. The Company has a growing global team spanning six continents who are driven by scientific excellence and exceptional speed to reach more patients than ever before. To learn more about BeOne, please visit www.beonemedicines.com<\/a> and follow us on LinkedIn<\/a>, X<\/a>, Facebook<\/a> and Instagram<\/a>.<\/p>

\nForward-Looking Statements\n<\/b>This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other federal securities laws, including statements regarding BeOne\u2019s plans, commitments, aspirations and goals related to BeOne\u2019s medicines and drug candidates. Actual results may differ materially from those indicated in the forward-looking statements as a result of various important factors which are discussed in the section entitled \u201cRisk Factors\u201d in BeOne\u2019s most recent periodic report filed with the U.S. Securities and Exchange Commission (\u201cSEC\u201d) as well as discussions of potential risks, uncertainties, and other important factors in BeOne\u2019s subsequent filings with the SEC. All information in this press release is as of the date hereof, and BeOne undertakes no duty to update such information unless required by law.<\/p> Contacts<\/b>

\nInvestor Contact:<\/b>Liza Heapes\nTel:+1 857-302-5663\nir@beonemed.com<\/a><\/p>

\nMedia Contact:<\/b>Kyle Blankenship\nTel:+1 667-351-5176\nmedia@beonemed.com<\/a><\/p>","protected":false},"excerpt":{"rendered":"

SAN CARLOS, Calif.–(BUSINESS WIRE)–$ONC #BeOne–BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will participate in the Goldman Sachs 47th Annual Global Healthcare Conference on June 8, 2026…<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-10827","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/10827","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=10827"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/10827\/revisions"}],"predecessor-version":[{"id":10828,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/10827\/revisions\/10828"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=10827"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=10827"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=10827"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}